Rare Diseases and Orphan Products: Accelerating Research...

Main
Rare Diseases and Orphan Products:...

Rare Diseases and Orphan Products: Accelerating Research and Development

Committee on Accelerating Rare Diseases Research and Orphan Product Development, Institute of Medicine

0 / 0

Quanto Você gostou deste livro?

Qual é a qualidade do ficheiro descarregado?

Descarregue o livro para avaliar a sua qualidade

De que qualidade são os ficheiros descarregados?

Ano:

2011

Edição:

1

Editora:

National Academies Press

Idioma:

english

Páginas:

443

ISBN 10:

0309158060

ISBN 13:

9780309158060

Arquivo:

PDF, 2.23 MB

IPFS:

,

english, 2011

Ler online

A converter para

Conversão para falhou

Você pode estar interessado em

Jules J. Berman (Auth.) — Rare Diseases and Orphan Drugs. Keys to Understanding and Treating the Common Diseases

Claudia Gonzaga-Jauregui, James R. Lupski — Genomics of Rare Diseases

Theresa Wizeman, Sally Robinson, Robert Giffin, Development, and Translation Forum on Drug Discovery, Institute of Medicine — Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Bo Yang, Yang Song, Yijie Zhou, (eds.) — Drug Development for Rare Diseases

David C Pryde; Michael J Palmer; Royal Society of Chemistry (Great Britain) — Orphan drugs and rare diseases

Elizabeth Hernberg-Stahl, Miroslav Reljanovic — Orphan drugs: Understanding the rare disease market and its dynamics

Remco L. A. de Vrueh (auth.), Rajeev K. Bali, Lodewijk Bos, Michael Christopher Gibbons, Simon Ibell (eds.) — Rare Diseases in the Age of Health 2.0

Stephen C. Groft, Manuel Posada de la Paz MD, PhD (auth.), Manuel Posada de la Paz, Stephen C. Groft (eds.) — Rare Diseases Epidemiology

Committee on Postmarket Surveillance of Pediatric Medical Devices — Safe Medical Devices for Children

Ronald Evens — Drug and Biological Development: From Molecule to Product and Beyond

DAVID CAVAIIA — OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

Decision Resources Inc — The SAGE Handbook of Healthcare (Sage Handbooks)

Ryan Abbott — Treating the Health Care Crisis: Complementary and Alternative Medicine for PPACA

Regulatory Affairs Professionals Society. — Fundamentals of Pharmaceutical and Biologics Regulations Volume I

Divya Vohora; Gursharan Singh — Pharmaceutical Medicine and Translational Clinical Research

United States — Office of Technology Assessment. Pharmaceutical R And D: Costs, Risks And Rewards

Carol M. Ashton, Nelda P. Wray — Comparative Effectiveness Research: Evidence, Medicine, and Policy

Raj Bawa — Current immune aspects of biologics and nanodrugs - an overview

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine — Extending Medicare Reimbursement in Clinical Trials

Board on Chemical Science and Technology and National Research Council — Rational Therapeutics for Infants and Children: Workshop Summary

Institute of Medicine — Assessing and Improving Value in Cancer Care: Workshop Summary

Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Institute of Medicine, Marilyn J. Field, Thomas F. Boat — Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act

Institute of Medicine; and Medical Devices Biologics Roundtable on Research and Development of Drugs; Ronald W. Estabrook; Janet Woodcock; Vivian P. Nolan; Jonathan R. Davis — Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making: Workshop Report

Clinical Professor Ronald P. Evens Pharm D., FCCP (auth.), Clinical Professor Ronald P. Evens Pharm D., FCCP (eds.) — Drug and Biological Development: From Molecule to Product and Beyond

Evan B. Siegel — Development and Approval of Combination Products: A Regulatory Perspective

Fran Hawthorne — Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat

Shreefal S. Mehta — Commercializing successful biomedical technologies: basic principles for the development of drugs, diagnostics and devices

James C Robinson — Purchasing Medical Innovation: The Right Technology, For the Right Patient, At the Right Price

James C. Robinson — Purchasing Medical Innovation: The Right Technology, for the Right Patient, at the Right Price

John Griffin, John O'Grady — Regulation of Medical Products

Thomas R. Fulda, Albert I. Wertheimer — Handbook of Pharmaceutical Public Policy

Richard A. Deyo; Donald L. Patrick — Hope or Hype : The Obsession with Medical Advances and the High Cost of False Promises

Henry I. Miller — To America's Health: A Proposal to Reform the Food and Drug Administration

Whitmore, Elaine — Development of FDA-Regulated Medical Products - Prescription Drugs, Biologics, and Medical Devices

Whitmore, Elaine — Development of FDA-Regulated Medical Products: A Translational Approach, Second Edition

Pronobesh Chattopadhyay & Danswrang Goyary — Modern Medicine Biomedical Devices, Medical Gases, Radiopharmaceuticals, New Drug Discovery, Volume 2

Cavalla, David — Off-label prescribing : justifying unapproved medicine

Iqbal Ramzan — Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians and Other Health Practitioners

Iqbal Ramzan — Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians, and Other Health Practitioners

Jeffrey S. Barrett — Fundamentals of Drug Development

Frases chave